Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Cainazzo MM"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-19 z 19
    Tytuł:
    Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real-world clinical evidence in a severely impaired patient population.
    Autorzy:
    Guerzoni S; Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse-Laboratory of Clinical Pharmacology and Pharmacogenomics, Department of Specialist Medicines, AOU Policlinico di Modena, Modena, Italy.
    Baraldi C; PhD School in Neurosciences, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Castro FL; Post-Gradute School in Pharmacology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Cainazzo MM; Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse-Laboratory of Clinical Pharmacology and Pharmacogenomics, Department of Specialist Medicines, AOU Policlinico di Modena, Modena, Italy.
    Pani L; Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse-Laboratory of Clinical Pharmacology and Pharmacogenomics, Department of Specialist Medicines, AOU Policlinico di Modena, Modena, Italy.; Pharmacology Unit, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Department of Psychiatry and Behavioral Sciences, University of Miami, Miami, Florida, USA.; VeraSci, Durham, North Carolina, USA.
    Pokaż więcej
    Źródło:
    Brain and behavior [Brain Behav] 2023 Jun; Vol. 13 (6), pp. e2799. Date of Electronic Publication: 2023 May 19.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Migraine Disorders*/drug therapy
    Migraine Disorders*/prevention & control
    Headache Disorders, Secondary*/drug therapy
    Humans ; Treatment Outcome ; Double-Blind Method ; Headache
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study.
    Autorzy:
    Geppetti P; Università degli studi di Firenze, Dipartimento di Scienze della Salute, Florence, Italy.; SOD Centro Cefalee e Farmacologia Clinica, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
    De Cesaris F; SOD Centro Cefalee e Farmacologia Clinica, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
    Benemei S; SOD Centro Cefalee e Farmacologia Clinica, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
    Cortelli P; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.; DIBINEM - Università di Bologna Ospedale Bellaria, Bologna, Italy.
    Cevoli S; DIBINEM - Università di Bologna Ospedale Bellaria, Bologna, Italy.
    Pierangeli G; DIBINEM - Università di Bologna Ospedale Bellaria, Bologna, Italy.; Azienda per l'Assistenza Sanitaria n. 5 Friuli Occidentale-Centro Cefalee, Presidio Ospedaliero di San Vito al Tagliamento, San Vito al Tagliamento, Italy.
    Favoni V; DIBINEM - Università di Bologna Ospedale Bellaria, Bologna, Italy.
    Lisotto C; Azienda per l'Assistenza Sanitaria n. 5 Friuli Occidentale-Centro Cefalee, Presidio Ospedaliero di San Vito al Tagliamento, San Vito al Tagliamento, Italy.
    Usai S; Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, UO Neurologia 3, Milan, Italy.
    Frediani F; Centro Cefalee, UOC Neurologia e Stroke Unit, Ospedale San Carlo Borromeo, ASST Santi Paolo e Carlo, Milan, Italy.
    Di Fiore P; Centro Cefalee, UOC Neurologia e Stroke Unit, Ospedale San Carlo Borromeo, ASST Santi Paolo e Carlo, Milan, Italy.
    D'Arrigo G; Centro Cefalee, UOC Neurologia e Stroke Unit, Ospedale San Carlo Borromeo, ASST Santi Paolo e Carlo, Milan, Italy.
    Tassorelli C; Headache Science & Neurorehabilitation Center, IRCCS C. Mondino Foundation Pavia, Pavia, Italy.; Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
    Sances G; Headache Science & Neurorehabilitation Center, IRCCS C. Mondino Foundation Pavia, Pavia, Italy.
    Cainazzo MM; AOU Policlinico di Modena, Struttura Semplice Dipartimentale -Centro Cefalee e Abuso di Farmaci e Tossicologia Medica, Modena, Italy.
    Baraldi C; Università degli studi di Modena e Reggio Emilia, Struttura Semplice Dipartimentale Centro Cefalee ed abuso di Farmaci-Tossicologia Medica, Modena, Italy.
    Sarchielli P; Headache Center, Neurological Clinic, University of Perugia, Perugia, Italy.
    Corbelli I; Headache, Center, Neurological Clinic, Azienda Ospedaliera Santa Maria della Misericordia, Perugia, Perugia, Italy.
    De Vanna G; Headache Center, Neurological Clinic, University of Perugia, Perugia, Italy.
    Tedeschi G; Department of Advanced Medical and Surgical Science, University of Campania 'Luigi Vanvitelli', Naples, Italy.
    Russo A; Department of Advanced Medical and Surgical Science, University of Campania 'Luigi Vanvitelli', Naples, Italy.
    Pokaż więcej
    Corporate Authors:
    Italian 17I-DCsc09 Study Team
    Źródło:
    Cephalalgia : an international journal of headache [Cephalalgia] 2022 Sep; Vol. 42 (10), pp. 1058-1070. Date of Electronic Publication: 2022 Apr 26.
    Typ publikacji:
    Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
    MeSH Terms:
    Diclofenac*/adverse effects
    Migraine Disorders*/chemically induced
    Migraine Disorders*/drug therapy
    Double-Blind Method ; Humans ; Infusions, Intravenous ; Pilot Projects
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache.
    Autorzy:
    Pensato U; Department of Biomedical and NeuroMotor Sciences of Bologna, University of Bologna, Bologna, Italy.
    Baraldi C; Medical Toxicology-Headache and Drug Abuse Research Centre, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Favoni V; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
    Mascarella D; Department of Biomedical and NeuroMotor Sciences of Bologna, University of Bologna, Bologna, Italy.
    Matteo E; Department of Biomedical and NeuroMotor Sciences of Bologna, University of Bologna, Bologna, Italy.
    Andrini G; Department of Biomedical and NeuroMotor Sciences of Bologna, University of Bologna, Bologna, Italy.
    Cainazzo MM; Medical Toxicology-Headache and Drug Abuse Research Centre, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Cortelli P; Department of Biomedical and NeuroMotor Sciences of Bologna, University of Bologna, Bologna, Italy.; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
    Pierangeli G; Department of Biomedical and NeuroMotor Sciences of Bologna, University of Bologna, Bologna, Italy.; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
    Guerzoni S; Medical Toxicology-Headache and Drug Abuse Research Centre, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Cevoli S; IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
    Pokaż więcej
    Źródło:
    Cephalalgia : an international journal of headache [Cephalalgia] 2022 Jun; Vol. 42 (7), pp. 645-653. Date of Electronic Publication: 2022 Feb 09.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Headache Disorders, Secondary*/chemically induced
    Headache Disorders, Secondary*/drug therapy
    Migraine Disorders*/chemically induced
    Migraine Disorders*/drug therapy
    Antibodies, Monoclonal/adverse effects ; Calcitonin Gene-Related Peptide Receptor Antagonists/therapeutic use ; Headache/chemically induced ; Humans ; Prospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data.
    Autorzy:
    Guerzoni S; Medical Toxicology-Headache and Drug Abuse Research Center, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Baraldi C; PhD School in Neuroscience, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy. .
    Pensato U; Post-Graduate School of Neurology, Department of Biomedical and Neuromotor Sciences of Bologna, University of Bologna, Bologna, Italy.
    Favoni V; IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy.
    Lo Castro F; Post-Graduate School of Pharmacology and Clinical Toxicology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Cainazzo MM; Medical Toxicology-Headache and Drug Abuse Research Center, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Cevoli S; IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy.
    Pani L; Medical Toxicology-Headache and Drug Abuse Research Center, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Pharmacology Unit, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Department of Psychiatry and Behavioral Sciences, University of Miami, Miami, USA.; VeraSci, Durham, NC, USA.
    Pokaż więcej
    Źródło:
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2022 Jun; Vol. 43 (6), pp. 3823-3830. Date of Electronic Publication: 2022 Jan 11.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Headache Disorders, Secondary*/drug therapy
    Migraine Disorders*/drug therapy
    Antibodies, Monoclonal, Humanized/adverse effects ; Calcitonin Gene-Related Peptide Receptor Antagonists/adverse effects ; Headache/drug therapy ; Humans
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache.
    Autorzy:
    Pensato U; Department of Biomedical and NeuroMotor Sciences of Bologna, University of Bologna, Bologna, Italy.
    Baraldi C; Medical Toxicology-Headache and Drug Abuse Research Centre, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Favoni V; IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy.
    Cainazzo MM; Medical Toxicology-Headache and Drug Abuse Research Centre, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Torelli P; Headache Centre, University Hospital of Parma, AOUPR, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy.
    Querzani P; Neurology Unit, S. Maria Delle Croci Hospital-AUSL Romagna, Ravenna, Italy.
    Pascazio A; Department of Biomedical and NeuroMotor Sciences of Bologna, University of Bologna, Bologna, Italy.
    Mascarella D; Department of Biomedical and NeuroMotor Sciences of Bologna, University of Bologna, Bologna, Italy.
    Matteo E; Department of Biomedical and NeuroMotor Sciences of Bologna, University of Bologna, Bologna, Italy.
    Quintana S; Headache Centre, University Hospital of Parma, AOUPR, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy.
    Asioli GM; Department of Biomedical and NeuroMotor Sciences of Bologna, University of Bologna, Bologna, Italy.
    Cortelli P; Department of Biomedical and NeuroMotor Sciences of Bologna, University of Bologna, Bologna, Italy.; IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy.
    Pierangeli G; Department of Biomedical and NeuroMotor Sciences of Bologna, University of Bologna, Bologna, Italy.; IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy.
    Guerzoni S; Medical Toxicology-Headache and Drug Abuse Research Centre, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Cevoli S; IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy. .
    Pokaż więcej
    Źródło:
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2022 Feb; Vol. 43 (2), pp. 1273-1280. Date of Electronic Publication: 2021 Jul 05.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Headache Disorders, Secondary*/drug therapy
    Migraine Disorders*/drug therapy
    Antibodies, Monoclonal, Humanized ; Calcitonin Gene-Related Peptide Receptor Antagonists ; Headache ; Humans ; Prospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Erenumab for the preventive treatment of chronic migraine complicated with medication overuse headache: an observational, retrospective, 12-month real-life study.
    Autorzy:
    Cainazzo MM; Medical Toxicology-Headache and Drug Abuse Research Center, Department of Specialized Medicine, AOU Policlinico di Modena, Via del Pozzo 71, 41124, Modena, Italy.
    Baraldi C; Doctoral School of Neuroscience, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41124, Modena, Italy. .
    Ferrari A; Medical Toxicology-Headache and Drug Abuse Research Center, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41124, Modena, Italy.
    Lo Castro F; Post-graduated School of Pharmacology and Clinical Toxicology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41124, Modena, Italy.
    Pani L; Medical Toxicology-Headache and Drug Abuse Research Center, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41124, Modena, Italy.; Pharmacology Unit, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Via Campi 287, 41124, Modena, Italy.; Department of Psychiatry and Behavioral Sciences, University of Miami, Miami, USA.; VeraSci, Durham, NC, USA.
    Guerzoni S; Medical Toxicology-Headache and Drug Abuse Research Center, Department of Specialized Medicine, AOU Policlinico di Modena, Via del Pozzo 71, 41124, Modena, Italy.
    Pokaż więcej
    Źródło:
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2021 Oct; Vol. 42 (10), pp. 4193-4202. Date of Electronic Publication: 2021 Feb 05.
    Typ publikacji:
    Journal Article; Observational Study
    MeSH Terms:
    Headache Disorders, Secondary*/drug therapy
    Migraine Disorders*
    Antibodies, Monoclonal, Humanized ; Calcitonin Gene-Related Peptide Receptor Antagonists ; Headache ; Humans ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Predictors of response to erenumab after 12 months of treatment.
    Autorzy:
    Baraldi C; PhD School in Neuroscience, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Castro FL; Post-graduate School of Pharmacology and Clinical Toxicology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Cainazzo MM; Medical Toxicology-headache and Drug Abuse Research Center, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Pani L; Medical Toxicology-headache and Drug Abuse Research Center, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Pharmacology Unit, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Department of Psychiatry and Behavioral Sciences, University of Miami, Miami, Florida, USA.; VeraSci, Durham, North Carolina, USA.
    Guerzoni S; Medical Toxicology-headache and Drug Abuse Research Center, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
    Pokaż więcej
    Źródło:
    Brain and behavior [Brain Behav] 2021 Aug; Vol. 11 (8), pp. e2260. Date of Electronic Publication: 2021 Jul 16.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Calcitonin Gene-Related Peptide Receptor Antagonists*
    Migraine Disorders*/drug therapy
    Migraine Disorders*/prevention & control
    Antibodies, Monoclonal, Humanized ; Humans ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Identification of candidate proteomic markers in the serum of medication overuse headache patients: An exploratory study.
    Autorzy:
    Pellesi L; Medical Toxicology, Headache and Drug Abuse Centre, University of Modena and Reggio Emilia, Modena, Italy.
    Guerzoni S; Medical Toxicology, Headache and Drug Abuse Centre, University of Modena and Reggio Emilia, Modena, Italy.
    Baraldi C; Medical Toxicology, Headache and Drug Abuse Centre, University of Modena and Reggio Emilia, Modena, Italy.
    Cainazzo MM; Medical Toxicology, Headache and Drug Abuse Centre, University of Modena and Reggio Emilia, Modena, Italy.
    Pini LA; Medical Toxicology, Headache and Drug Abuse Centre, University of Modena and Reggio Emilia, Modena, Italy.; Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy.
    Bellei E; Department of Surgery, Medicine, Dentistry and Morphological Science with Transplant Surgery, Oncology and Regenerative Medicine Relevance, Proteomic Lab, University of Modena and Reggio Emilia, Modena, Italy.
    Pokaż więcej
    Źródło:
    Cephalalgia : an international journal of headache [Cephalalgia] 2020 Sep; Vol. 40 (10), pp. 1070-1078. Date of Electronic Publication: 2020 Apr 29.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Biomarkers/*blood
    Headache Disorders, Secondary/*blood
    Adult ; Aged ; Chromatography, Liquid/methods ; Electrophoresis, Gel, Two-Dimensional/methods ; Female ; Humans ; Male ; Middle Aged ; Proteomics/methods ; Tandem Mass Spectrometry/methods
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication-overuse headache.
    Autorzy:
    Pellesi L; Medical Toxicology, Headache and Drug Abuse Centre, University of Modena and Reggio Emilia, Modena, Italy. .
    Bellei E; Department of Diagnostic Medicine, Clinic and Public Health, Proteomic Lab, University of Modena and Reggio Emilia, Modena, Italy.
    Guerzoni S; Medical Toxicology, Headache and Drug Abuse Centre, University of Modena and Reggio Emilia, Modena, Italy.
    Cainazzo MM; Medical Toxicology, Headache and Drug Abuse Centre, University of Modena and Reggio Emilia, Modena, Italy.
    Baraldi C; Medical Toxicology, Headache and Drug Abuse Centre, University of Modena and Reggio Emilia, Modena, Italy.
    Monari E; Department of Diagnostic Medicine, Clinic and Public Health, Proteomic Lab, University of Modena and Reggio Emilia, Modena, Italy.
    Pini LA; Medical Toxicology, Headache and Drug Abuse Centre, University of Modena and Reggio Emilia, Modena, Italy.; Center for Neuroscience and Neurotechnology, University of Modena and Reggio Emilia, Modena, Italy.
    Pokaż więcej
    Źródło:
    BMC neurology [BMC Neurol] 2019 Oct 17; Vol. 19 (1), pp. 239. Date of Electronic Publication: 2019 Oct 17.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Biomarkers/*blood
    Headache Disorders, Secondary/*blood
    Adult ; Animals ; Chronic Pain/blood ; Female ; Headache Disorders/blood ; Humans ; Male ; Middle Aged ; Proteomics ; Rats
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-19 z 19

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies